Oragenics (OGEN) Stock Statistics & Valuation Metrics

Oragenics has a market cap or net worth of $4.20M. The enterprise value is $3.08M.

Oragenics has 21,475,288 shares outstanding. The number of shares has decreased by -2.65% in one year.

Oragenics’s return on equity (ROE) is 49.88 and return on invested capital (ROIC) is -9052.25%.

The current PE Ratio of Oragenics is -0.23. Oragenics’s PEG ratio is >-0.01.

In the last 12 months, Oragenics had revenue of 0.00 and earned -10.57M in profits. Earnings per share was -1.60.

In the last 12 months, operating cash flow was -8.60M and capital expenditures 0.00, giving a free cash flow of -8.60M billion.

Oragenics pays an annual dividend of ―, resulting in a dividend yield of ―

Oragenics upcoming earnings date is Aug 12, 2024, TBA Not Confirmed.

Oragenics as a current ratio of 0.87, with Debt / Equity ratio of -155.05%

In the past 12 months, Oragenics has paid 0.00 in taxes.

Oragenics EV to EBITDA ratio is -0.18, with an EV/FCF ratio of -0.22.

Oragenics has $864.84K in cash and marketable securities with $328.53K in debt, giving a net cash position of -$536.31K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Oragenics is ―, which is 11.43% higher than the current price. The consensus rating is ―